About the Authors
- Suvi T. Vaara
-
* E-mail: suvi.vaara@helsinki.fi
Affiliation Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Maija Hollmén
-
Affiliation Medicity Research Laboratory and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland
- Anna-Maija Korhonen
-
Affiliation Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Mikael Maksimow
-
Affiliation Medicity Research Laboratory and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland
- Tero Ala-Kokko
-
Affiliation Department of Anaesthesiology, University of Oulu and Division of Intensive Care Medicine, Oulu University Hospital, Medical Research Centre Oulu, Oulu, Finland
- Marko Salmi
-
Affiliation Medicity Research Laboratory and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland
- Sirpa Jalkanen
-
Affiliation Medicity Research Laboratory and Department of Medical Microbiology and Immunology, University of Turku, Turku, Finland
- Ville Pettilä
-
Affiliations Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Department of Intensive Care Medicine, Bern University Hospital (Inselspital), University of Bern, Bern, Switzerland
- FINNAKI Study Group
-
¶Membership of the FINNAKI Study Group is listed in the Acknowledgments.
Competing Interests
VP is a Steering Committee member for INTEREST study in ARDS patients. SJ, MH, MM and MS own stocks of Faron Pharmaceuticals. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors declare no competing interests.
Author Contributions
Conceptualization: SJ VP. Data curation: STV. Formal analysis: STV. Funding acquisition: SJ VP. Investigation: STV MH AMK MM TAK MS SJ VP FINNAKI Study Group. Methodology: MH MM MS STV. Project administration: SJ VP. Supervision: SJ VP. Visualization: STV. Writing – original draft: STV. Writing – review & editing: STV MH AMK MM TAK MS SJ VP.